da Vinci SP® Investigational Device Exemption Study in Colorectal Procedures
← catalyst calendarSponsored by Intuitive Surgical (industry) · ISRG — their whole pipeline →.
Phase
Not applicable
Status
Active, not recruiting
Study type
Interventional
Design
Non randomized · None · Other
Enrollment
60actual
Sites
9
Countries
South Korea, United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2021-06-03 | actual | When the study began enrolling |
| Primary completion | 2023-09-30 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2028-11-30 | estimated | The whole study's end, after follow-up |
| First posted | 2020-05-27 | actual | When this record first appeared on the registry |
| Results posted | 2026-06-03 | actual | When the sponsor posted results to the registry |
| Record updated | 2026-06-03 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Colorectal Cancer
- Benign or Malignant Rectal or Colon Tumors
Intervention
- Device: Robotic Assisted Surgery
Primary outcomes
what the primary-completion date above is the date OFRate of Conversion
measured IntraOperative period
Major Adverse Events Rates
measured Intraoperative through the 42-day postoperative period
Posted documents
hosted by the registry — we link, never re-serveStudy Protocol and Statistical Analysis Planposted 2023-01-31 · 203 KB · Prot_SAP_001.pdf
Permalink · ISRG's whole pipeline · Catalyst calendar · Every registered study · What changed